Analyst consensus rating
Roivant Sciences Analyst Rating: Strong Buy
ROIV is rated Strong Buy by 11 analysts with a $41.82 target. As of 2026-08-30.
Direct answer
Roivant Sciences's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $41.82.
Forecast evidence checked August 30, 2026.
Get free Roivant Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $34.71
- Average price target
- $41.82
- High price target
- $50.00
- Low price target
- $37.00
- Low target gap
- +6.6%
- Target upside
- +20.5%
- High target gap
- +44.1%
- Target range width
- 37.5%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Roivant Sciences?
Roivant Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $41.82.
How far are Roivant Sciences's low and high targets from the recorded price?
The low target implies +6.6%, while the high target implies +44.1%.
How many analysts are included in Roivant Sciences's consensus?
The verified consensus includes 11 analysts.
How is Roivant Sciences's target upside or downside calculated?
The average target of $41.82 is divided by the recorded price of $34.71, then one is subtracted to produce +20.5%. This does not guarantee a future return.
When was Roivant Sciences's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.